RECELL® / RECELL GO® (≤1920cm²)
Deep Partial / Full-Thickness Burns
Key Facts
About AVITA Medical
AVITA Medical is a commercial-stage regenerative medicine company focused on transforming acute wound care through its proprietary autologous cell harvesting technology. Its FDA-approved RECELL System is the cornerstone of a platform designed to harness a patient's own skin for healing, with applications expanding beyond burns into traumatic and surgical wounds. The company is actively advancing its pipeline through clinical trials, supported by a commercial infrastructure in the U.S. and international approvals, aiming to improve clinical outcomes and reduce healthcare costs. AVITA's strategy centers on leveraging its core technology across multiple indications while commercializing a portfolio of advanced wound care products.
View full company profileAbout AVITA Medical
AVITA Medical is a commercial-stage regenerative medicine company focused on transforming acute wound care through its proprietary autologous cell harvesting technology. Its FDA-approved RECELL System is the cornerstone of a platform designed to harness a patient's own skin for healing, with applications expanding beyond burns into traumatic and surgical wounds. The company is actively advancing its pipeline through clinical trials, supported by a commercial infrastructure in the U.S. and international approvals, aiming to improve clinical outcomes and reduce healthcare costs. AVITA's strategy centers on leveraging its core technology across multiple indications while commercializing a portfolio of advanced wound care products.
View full company profileAbout AVITA Medical
AVITA Medical is a commercial-stage regenerative medicine company focused on transforming acute wound care through its proprietary autologous cell harvesting technology. Its FDA-approved RECELL System is the cornerstone of a platform designed to harness a patient's own skin for healing, with applications expanding beyond burns into traumatic and surgical wounds. The company is actively advancing its pipeline through clinical trials, supported by a commercial infrastructure in the U.S. and international approvals, aiming to improve clinical outcomes and reduce healthcare costs. AVITA's strategy centers on leveraging its core technology across multiple indications while commercializing a portfolio of advanced wound care products.
View full company profileTherapeutic Areas
Other Deep Partial / Full-Thickness Burns Drugs
| Drug | Company | Phase |
|---|---|---|
| RECELL GO Mini™ (≤480cm²) | AVITA Medical | Submission |